Alltech and Masterfeeds have entered into a share purchase, under which Alltech will acquire 100% of the outstanding shares of Masterfeeds, Inc., from Ag Processing Inc (AGP). This will give Alltech complete ownership of Masterfeeds LP, a leading commercial animal nutrition company in Canada.
“This is a crucial time in agriculture, and Canadian farmers are facing ever-increasing pressures, including the continued drive to produce more with fewer resources,” said Dr. Pearse Lyons, founder and president of Alltech. “Masterfeeds provides the on-farm support that is critical to Canada’s farmers and ranchers. This new opportunity will enable more efficient delivery of superior animal nutrition and tailored feeding programs, supported by robust scientific research.”
Masterfeeds further strengthens Alltech’s presence in Canada by creating one of the country’s largest animal nutrition offerings. Alltech, Masterfeeds and EMF Nutrition, another Alltech-owned Canadian company, employ approximately 700 Canadians, operating 25 feed manufacturing and premix facilities, nine retail locations and seven distribution centers in a business spanning the entire country.
“Alltech’s investment strategy is unfolding in exciting ways,” stated Rob Flack, president and CEO of Masterfeeds. “Alltech’s primacy in science, supported by an extensive research and development program, is both cutting-edge and relevant. Masterfeeds’ proven on-farm feeding solutions will be strengthened through proprietary Alltech nutrition technology, adding further value to our customers throughout Canada.”
Masterfeeds will continue to be headquartered in London, Ontario, Canada, and led by its current Chief Executive Officer, Rob Flack. In addition, Alltech’s own entity, Alltech Canada, remains headquartered in Guelph, Ontario, serving the entire Canadian feed industry. The combined company will have a presence in 128 countries with more than 4,700 employees worldwide. Both parties expect the acquisition to result in significant new synergies over time.
Completion of the acquisition is expected by year-end and is subject to the execution of typical conditions, including regulatory approvals.